Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China
· Delayed Price · Currency is CNY 85.47
-1.03 (-1.19%)
Apr 24, 2025, 2:45 PM CST
SHA:688016 Revenue
In the year 2024, Shanghai MicroPort Endovascular MedTech had annual revenue of 1.21B CNY with 1.61% growth. Shanghai MicroPort Endovascular MedTech had revenue of 236.76M in the quarter ending December 31, 2024, a decrease of -20.75%.
Revenue
1.21B
Revenue Growth
+1.61%
P/S Ratio
8.66
Revenue / Employee
1.33M
Employees
908
Market Cap
10.45B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.77B |
| Aier Eye Hospital Group | 20.62B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |